EF Hutton Initiates Coverage On Hudson Technologies with Buy Rating, Announces Price Target of $11
July 11, 7:10 AM
EF Hutton analyst Chip Moore initiates coverage on Hudson Technologies (NASDAQ:HDSN) with a Buy rating and announces Price Target of $11.
Citigroup Downgrades Pulmonx to Neutral, Lowers Price Target to $19
July 11, 7:08 AM
Citigroup analyst Joanne Wuensch downgrades Pulmonx (NASDAQ:LUNG) from Buy to Neutral and lowers the price target from $23 to $19.
Ionis Partner Roche Licenses Rare Kidney Disease Treatment and Will Advance into Phase 3 Clinical Study
July 11, 7:06 AM
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), today announced that its long-standing partner, Roche, will license and advance IONIS-FB-LRx, an investigational antisense medicine, into a Phase 3 clinical study in patients with immunoglobulin A nephropathy (IgAN).
UBS Downgrades T. Rowe Price Gr to Sell, Lowers Price Target to $88
July 11, 7:04 AM
UBS analyst Brennan Hawken downgrades T. Rowe Price Gr (NASDAQ:TROW) from Neutral to Sell and lowers the price target from $138 to $88.
Can-Fite To Submit FDA & EMA Registration Plans For Piclidenoson In The Oral Treatment Of Moderate To Severe Psoriasis
July 11, 7:02 AM
Further analysis of Phase III COMFORT™ data show Piclidenoson's superior safety profile and higher patient compliance compared to Otezla®
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CFBI), a
B of A Securities Initiates Coverage On System1 with Buy Rating, Announces Price Target of $12
July 11, 6:59 AM
B of A Securities analyst Nat Schindler initiates coverage on System1 (NYSE:SST) with a Buy rating and announces Price Target of $12.
Loop Capital Initiates Coverage On Boyd Gaming with Buy Rating, Announces Price Target of $86
July 11, 6:58 AM
Loop Capital analyst Daniel Adam initiates coverage on Boyd Gaming (NYSE:BYD) with a Buy rating and announces Price Target of $86.
Piper Sandler Maintains Overweight on Bancorp, Lowers Price Target to $31
July 11, 6:56 AM
Piper Sandler analyst Frank Schiraldi maintains Bancorp (NASDAQ:TBBK) with a Overweight and lowers the price target from $36 to $31.
Wells Fargo Downgrades CNX Resources to Equal-Weight, Raises Price Target to $27
July 11, 6:54 AM
Wells Fargo analyst Nitin Kumar downgrades CNX Resources (NYSE:CNX) from Overweight to Equal-Weight and raises the price target from $26 to $27.